

[ Fri, May 28th 2021
] - WOPRAI

[ Fri, Nov 13th 2020
] - WOPRAI

[ Wed, Apr 15th 2020
] - WOPRAI

[ Thu, Mar 12th 2020
] - WOPRAI

[ Mon, Jan 14th 2019
] - WOPRAI

[ Fri, Sep 28th 2018
] - WOPRAI

[ Wed, Jul 25th 2018
] - WOPRAI

[ Tue, Jun 05th 2018
] - WOPRAI


[ Thu, Mar 16th 2017
] - WOPRAI
Matthew Gillmor Initiated (TDOC) at Hold and Held Target at $162 on, May 28th, 2021
Matthew Gillmor of Baird, Initiated "Teladoc Health, Inc." (TDOC) at Hold and Held Target at $162 on, May 28th, 2021.
Matthew has made no other calls on TDOC in the last 4 months.
There are 11 other peers that have a rating on TDOC. Out of the 11 peers that are also analyzing TDOC, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Windley of "Jefferies" Maintained at Hold with Decreased Target to $248 on, Thursday, February 25th, 2021
These are the ratings of the 10 analyists that currently disagree with Matthew
- Jailendra Singh of "Credit Suisse" Maintained at Buy with Decreased Target to $264 on, Friday, April 30th, 2021
- David Larsen of "BTIG" Maintained at Strong Buy with Decreased Target to $300 on, Thursday, April 29th, 2021
- Donald Hooker of "Keybanc" Maintained at Buy with Decreased Target to $220 on, Thursday, April 29th, 2021
- Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $295 on, Thursday, April 29th, 2021
- Ryan MacDonald of "Needham" Initiated at Strong Buy and Held Target at $235 on, Thursday, April 15th, 2021
- George Hill of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $226 on, Wednesday, March 17th, 2021
- Hannah Baade of "DA Davidson" Maintained at Strong Buy with Increased Target to $275 on, Thursday, February 25th, 2021
- Sean Wieland of "Piper Sandler" Maintained at Buy with Decreased Target to $291 on, Thursday, February 25th, 2021
- Stephanie Davis of "SVB Leerink" Maintained at Buy with Increased Target to $266 on, Thursday, February 25th, 2021
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Increased Target to $270 on, Thursday, February 25th, 2021
Contributing Sources